Influence of decalcification procedures on immunohistochemistry and molecular pathology in breast cancer

Metastatic Breast Cancer, Version 1.2012

(2017) Robert W. Carlson et al.   Journal of the National Comprehensive Cancer Network

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

(2015) Catherine Van Poznak et al.   JOURNAL OF CLINICAL ONCOLOGY

CytoLyt® Fixation and Decalcification Pretreatments Alter Antigenicity in Normal Tissues Compared With Standard Formalin Fixation

(2015) Jennette R. Gruchy et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patients

(2014) M. Harries et al.   Cancer Epidemiology

Effects of tissue decalcification on the quantification of breast cancer biomarkers by digital image analysis

(2014) Arkadiusz Gertych et al.   Diagnostic Pathology

A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer

(2014) Fatemeh Bahreini et al.   Breast Cancer

Analysis of the effect of various decalcification agents on the quantity and quality of nucleic acid (DNA and RNA) recovered from bone biopsies

(2013) Veena M. Singh et al.   Annals of Diagnostic Pathology

Incidence of bone metastases in breast cancer patients in the United Kingdom: Results of a multi-database linkage study using the general practice research database

(2013) Katrina Wilcox Hagberg et al.   Cancer Epidemiology

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

Functional DNA quantification guides accurate next-generation sequencing mutation detection in formalin-fixed, paraffin-embedded tumor biopsies

(2013) Sachin Sah et al.   Genome Medicine

Discrepancies between primary tumor and metastasis: A literature review on clinically established biomarkers

(2012) Stéphane Vignot et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Testing for Discordance at Metastatic Relapse of Breast Cancer Matters

(2012) Paul J. van Diest et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluating Methods for Isolating Total RNA and Predicting the Success of Sequencing Phylogenetically Diverse Plant Transcriptomes

(2012) Marc T. J. Johnson et al.   PLoS One

Impact of Decalcification on Receptor Status in Breast Cancer

(2011) Farbod Darvishian et al.   Breast Journal

Influence of different decalcifying agents on EGF and EGFR immunostaining

(2010) Juliana dos Santos Neves et al.   ACTA HISTOCHEMICA

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

(2010) M. Elizabeth H. Hammond et al.   Journal of Oncology Practice

Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC)

(2009) M. Arnedos et al.   ANNALS OF ONCOLOGY

Technical pitfalls potentially affecting diagnoses in immunohistochemistry

(2008) G Bussolati et al.   JOURNAL OF CLINICAL PATHOLOGY